Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Pluto Bio logo — Translational science infrastructure for drug discovery tea...

Pluto Bio

Translational science infrastructure for drug discovery teams

Founded 2020 United States Denver, United States 23 employees Seed Total: $4.70M Analytics, Data Analytics +4

General Information

Company Name Pluto Bio
Founded Year 2020
Location United States Denver, United States
Employees 23
Industries Analytics, Data Analytics, Life Sciences +3
Funding Stage Seed
Business Model SaaS, B2B, Platform
Revenue Model Subscription, Service Fee, Usage Based
Offices as of Nov 2026
Denver, United States
Social

BounceWatch is an independent company data service, not affiliated with Pluto Bio. To contact Pluto Bio, visit pluto.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pluto Bio compare?

A PDF of Pluto Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pluto Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Homepage Update

Significant changes detected on company website (98.8% content change).

Feature Release Nov 04, 2026

Pluto Bio launched the Pluto MCP connector, integrating translational science data with AI assistants like ChatGPT and Claude.

Event Participation Oct 23, 2026

Pluto Bio will be participating in the #AIDDD event in Boston next week.

Pluto Bio a competitor of yours? Have our desk watch it

AI Insight

Bounce Watch AI
4 days ago

Pluto Bio has recently launched its Pluto MCP connector, a strategic move to integrate translational science data with leading AI assistants like ChatGPT and Claude for natural language querying. This significant product enhancement, coinciding with a major website update and upcoming event participation, signals a clear strategic shift towards AI-driven decision support and enhanced user accessibility in drug discovery. The company is positioning itself at the forefront of intelligent biotech solutions, aiming to redefine how scientific teams interact with complex multi-omics data.

Signal Types
Product Launch Market Presence Website Activity
Strategic Labels
AI Integration Product Innovation Market Positioning
Next Move: Hiring
·
Impact: 8/10
·
Ideal For: AI-Driven Biotech Investors — Seed to Series A

About Pluto Bio

Pluto Bio offers a transformative platform for drug discovery teams, epitomized by its slogan: "Translational science infrastructure for drug discovery teams." Unlike typical platforms that merely provide data, Pluto Bio empowers translational teams to articulate scientific queries within a comprehensive framework, fostering alignment on scientific objectives.

The platform allows delegating multi-omics data analysis to either in-house scientists or Pluto Bio's agents, enhancing precision in data interpretation. This approach generates verifiable evidence addressing pivotal program criteria. Additionally, users can create publication-ready visuals and comprehensive reports, streamlining program benchmarking across portfolios.

Founded in 2020 and headquartered in the United States, Pluto Bio operates within sectors spanning Analytics, Life Sciences, SaaS, and Machine Learning. In a recent Seed Round on 02 May 2023, they secured a $3.70M investment from Silverton Partners, showcasing investor confidence in their innovative capabilities.

Business keywords: Translational Science, Drug Discovery, Multi-omics Data Analysis, Scientific Questions Framework, Traceable Evidence Generation, Publication-ready Figures, Executive Reporting, B2B SaaS Platform, Data Organization, Machine Learning-based Analysis, Scientific Reproducibility, Experiment Comparison, Global Scientific Community, Biomarker Discovery, Scientific Communication

Services & Products

Bioinformatics Analysis
Data Management Platform
AI-Driven Decision Support
Collaborative Research Tools
Scientific Visualization Tools

Target Customers

Pharmaceutical Companies Biotechnology Firms Academic Research Institutions Contract Research Organizations (CROs) Bioinformaticians Principal Investigators CSOs

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $3.70M 1
Silverton Partners
Silverton Partners
02 May 2023
Seed Round $1.00M 1
Christopher Glode
12 Oct 2021

Pluto Bio Alternatives & Competitors

View All Alternatives
Pluto Bio vs
Elucidata
Elucidata United States

The AI Partner Fueling
40+ FDA-Track Drugs

Series A
167 employees
AI, Analytics
Compare Pluto Bio vs Elucidata
Pluto Bio vs
Medical Writing - Emtex Life Science
Medical Writing - Emtex Life Science Belgium

Medical writing and related services. We are committed to providing high quality documents. Passion...

26 employees
Analytics, Life Sciences
Pluto Bio vs
Partex.AI Technology
Partex.AI Technology India

The experts in AI technology for drug discovery and development.

Series C
182 employees
AI, Analytics
View all alternatives

FAQ About Pluto Bio

Translational science infrastructure for drug discovery teams
Pluto Bio was founded in 2020.
Pluto Bio is headquartered in Denver, United States.
Pluto Bio operates in Analytics, Data Analytics, Life Sciences, SaaS, Clean Energy and Machine Learning. Its work centres on Translational Science, Drug Discovery, Multi-omics Data Analysis and Scientific Questions Framework. Its customers include Pharmaceutical Companies, Biotechnology Firms and Academic Research Institutions.
Pluto Bio has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Service Fee and Usage Based.
Pluto Bio has approximately 23 employees.
Pluto Bio has completed 2 funding rounds, raising a total of $4.70M. The latest funding stage is Seed.
Pluto Bio offers: Bioinformatics Analysis, Data Management Platform, AI-Driven Decision Support, Collaborative Research Tools, Scientific Visualization Tools.
Top alternatives and competitors to Pluto Bio include Elucidata, Medical Writing - Emtex Life Science, Partex.AI Technology, Galatea Bio Inc., Bitfount. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pluto Bio and Elucidata are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pluto Bio, https://www.bouncewatch.com/company/pluto-1, updated 8 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout